+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Allergy Diagnostics - Global Market Trajectory & Analytics

  • ID: 4805131
  • Report
  • September 2020
  • Region: Global
  • 689 pages
  • Global Industry Analysts, Inc
1 of 2
The global market for Allergy Diagnostics is projected to reach US$6.4 billion by 2025, driven by the rise in allergies across all age groups. Several reasons have been theorized for this rise including global warming. The rise in temperatures is extending the growing season for plants resulting in increased pollen in the air, a chief cause for respiratory allergies. Hygiene hypothesis is presented as another reason where excessive focus on cleanliness and increased use of sanitizers and disinfectants is reducing exposure to bacteria and viruses which in reality is vital in training the immune system to fight infections. The result is the development of an immune system untaught by infections and parasites to recognize real threats. Children and adults therefore tend to develop hyperactive immune systems incapable of differentiating harmless substances from the harmful substances. Food allergies especially in children has doubled and one the reasons is the overuse of antibiotics and other drugs that reduce acid production in the stomach. This alters the behavior and function of the gastrointestinal tract inducing allergic reactions to food. Also, delayed introduction of certain foods in babies is also a key factor for developing food allergies later in life. Studies have revealed that over 25% of toddlers not introduced to peanuts in their diet go on to develop peanut allergy. Few of the common food allergies include eggs, tree nuts, peanuts, shellfish, wheat, soy, fish, among others. Vitamin D hypothesis associates deficiency or hypovitaminosis D with increased asthma and allergic rhinitis prevalence. New studies are revealing insights into the pleiotropic effects of vitamin D. Vitamin D is increasingly being recognized as an immunomodulator and its supplementation is gaining prominence in the treatment of allergic diseases. The most interesting of the reasons put forward for the prevalence of allergies is the hidden Neanderthal DNA present in modern humans. Inter-species breeding between modern humans and ape-like species called the Neanderthals and Denisovans about 50,000 years ago is believed to be responsible for our susceptibility to allergies by influencing the genetic diversity in present-day immunity genes belonging to the human Toll-like-receptor (TLRs) family. All humans today carry trace amounts of Neanderthal DNA in the range of 1% to 6%.

Whatever maybe the reason for the rise in allergies, the scenario is throwing the spotlight on the state of allergy care worldwide, which continues to be chronically under-resourced, under-supplied with high unmet diagnostic and treatment needs. Allergy diagnostics and treatment are therefore expected to witness robust untapped potential for growth with the need of the hour being a holistic integrated approach to allergy management. The robust commercial rewards, in this space, will induce more intensive R&D for the development of non-invasive, painless, needle free allergy testing and screening methods. While the skin prick test remains popular and widespread, companies are developing innovative pain and scar-free alternatives such as single drop blood tests. The mast cell activation test (MAT) which uses blood (serum) is an example in this space. Rising in prominence is molecular allergology aimed at more accurately identifying and managing IgE-mediated allergic reactions and disorders like allergic respiratory diseases, food allergies, and anaphylaxis. Growth in the market hinges on the progress made in quantifying and benchmarking specific IgE responsible for the allergy. Specific IgE testing has the benefit of providing valuable diagnostic and prognostic information on serious allergies. AllerGenis LLC has broken new grounds in the long-stagnant allergy diagnostics market with its proprietary Luminex`s bead-based xMAP® technology capable of isolating allergenic proteins into smaller peptides called epitopes for easy identification. The United States and Europe represent large markets worldwide with a combined share of 60.7% of the market. China ranks as the fastest growing market with a CAGR of 15% over the analysis period supported by rising rates of skin allergies and high number of misdiagnosis of food allergies due to imprecise tests.

Competitors identified in this market include, among others:
  • Alk-Abello A/S
  • Allergy Therapeutics PLC
  • Angsana Molecular & Diagnostics Laboratory Pte. Ltd.
  • Astra Biotech Gmbh
  • biomerieux SA
  • Danaher Corporation
  • Demeditec Diagnostics GmbH
  • EUROIMMUN AG
  • GA Generic Assays GmbH
  • Hitachi Chemical Co., Ltd.
  • INDOOR Biotechnologies, Inc.
  • Lincoln Diagnostics, Inc.
  • Omega Diagnostics Group Plc
  • R-Biopharm Ag
  • Roxall Medizin GmbH
  • Stallergenes Greer
  • Siemens Healthineers
  • Tecan Trading AG
  • Theradiag
  • Thermo Fisher Scientific Inc.
Note: Product cover images may vary from those shown
2 of 2
I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
  • Allergens: A Prelude
  • Key Allergy Stats
  • Allergy: Symptoms and Causes
  • Global Allergy Diagnostics Market Set to Witness Rapid Growth
  • With Allergies on the Rise for Whatever Reason Be It Our Neanderthal Genes or Hygiene Hypothesis or Vitamin D Hypothesis, the Need for Effective Diagnostics Has Never Been Greater
  • Global Prevalence of Allergies (In Million)
  • Assay Kits Dominate the Allergy Diagnostics Market
  • Inhaled Allergens Segment to Witness Fastest Growth
  • US Dominates the Allergy Diagnostics Market, While China to Witness the Fastest Growth
  • World Allergy Diagnostics Market by Region (2019 & 2025): Percentage Breakdown of Dollar Sales for Developed and Developing Regions
  • World Allergy Diagnostics Market - Geographic Regions Ranked by Volume CAGR for 2018-2025: China, Asia-Pacific, Latin America, Middle East, Canada, USA, Africa, Europe, and Japan
  • Rising Demand for In-Vitro Diagnostic Tests for Allergy Diagnosis
  • Global In-Vitro Diagnostics (IVD) Market Revenues (in %) by Segment for the Year 2019
  • Global In-Vitro Diagnostics (IVD) Market Revenues (in %) by Geographic Region for the Year 2019
  • Impact of Covid-19 and a Looming Global Recession
  • Competitive Landscape
  • Allergy Diagnostics Competitor Market Share Scenario Worldwide (in %): 2019
2. FOCUS ON SELECT PLAYERS
  • Alk-Abello A/S (Denmark)
  • Allergy Therapeutics PLC (UK)
  • Angsana Molecular & Diagnostics Laboratory Pte. Ltd. (Singapore)
  • Astra Biotech Gmbh (Germany)
  • biomerieux SA (France)
  • Danaher Corporation (USA)
  • Demeditec Diagnostics GmbH (Germany)
  • EUROIMMUN AG (Germany)
  • GA Generic Assays GmbH (Germany)
  • Hitachi Chemical Co., Ltd. (Japan)
  • INDOOR Biotechnologies, Inc. (USA)
  • Lincoln Diagnostics, Inc. (USA)
  • Omega Diagnostics Group Plc (UK)
  • R-Biopharm Ag (Germany)
  • Roxall Medizin GmbH (Germany)
  • Stallergenes Greer (UK)
  • Siemens Healthineers (Germany)
  • Tecan Trading AG (Switzerland)
  • Theradiag (France)
  • Thermo Fisher Scientific Inc. (USA)
3. MARKET TRENDS & DRIVERS
  • Development of Effective Allergy Diagnostic Products Cuts Down on Healthcare Spending
  • World Healthcare Expenditure (In US$ Trillion) for the Years 2017, 2019, 2021 & 2023
  • Per Capita Healthcare Expenditure (in $) by Select Countries for 2018
  • Labs Embrace Automation and Advanced Allergy Tests for Fast Turnaround Times
  • Need to Offer Quality Services at Affordable Costs Prompts Labs to Consider Reagent Rental Agreements
  • In-Vitro IgE Molecular Diagnostics to Transform Allergy Testing Market
  • Macro Array Diagnostics Unveils Allergy Explorer for Allergy Diagnostics
  • Rising Alcohol and Drug Abuse Increases Demand for Allergy Diagnostics
  • Increasing Cases of Allergies Drive Development of Advanced Allergy Diagnostics Solutions
  • Focus on Single and Protein Allergens
  • IgE Antibody Tests
  • Allergy Diagnostic Reagents on Microchip
  • Allergy Diagnosis Moves from Lab-based to Decentralized POC Tests
  • Patch Test to Experience Healthy Growth
  • SmartPractice Secures FDA Approval for T.R.U.E. Test(R) Patch Test for Pediatric Use
  • Providers of Allergy Diagnostic Services Focus on Vertical Integration
  • Allergic Diagnostic Challenges in Patients
  • Enhanced Access to Allergy Diagnosis Medical Insurance & Instrument Allowancesin the US Widen Market Prospects
  • Typical Cost Structure for Allergy Testing
  • Select Digital Technologies to Provide Help in Managing Food Allergy
  • Select Recent Launches in the Allergy Diagnostics Market to Bolster Market Expansion
  • EUROIMMUM Develops EUROLINE DPA-Dx Pollen Southern Europe 1 Test for Pollen Allergies
  • Hycor Biomedical Secures FDA Clearance for NOVEOS Allergy Testing System
  • ASI Introduces IVT Allergy(R) 3 Screen Panel for Allergy Skin Testing
  • CLA-1(TM) Luminometer In-Vitro Allergy Testing Platform for Accurate, Reliable Results
  • Growth Drivers
  • Increasing Prevalence and Incidence of Allergic Disorders to Drive the Demand for Allergy Diagnostics
  • Atopic Dermatitis (Eczema) Prevalence Rates among Global Adult Population
  • Environmental Changes and Pollution Aggravate Incidence of Allergic Reactions, Resulting in Increased Need for Allergy Diagnostics
  • Major Environmental Factors with Link to Allergic Diseases
  • Growing Number of Food Allergy Cases Fuels Demand for Allergy Testing Kits
  • Prevalence Rate of Five Common Food Allergies among US Adults
  • Factors Responsible for Rising Prevalence of Food Allergy
  • Burgeoning Aging Population and Longer Life Expectancy to Drive Allergy Diagnostics Market
  • Global Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
  • Market Restraints
  • Inadequate Knowledge about Food Allergy Inhibits Growth of Allergy Diagnostic Market
  • Expensive Nature of Allergy Diagnostics Approaches Limits Market Growth
  • New Regulations and Statutory Provisions to Affect Diagnostic Allergen Extracts
4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES
  • Market Facts & Figures
  • Allergy Prevalence Statistics
  • Incidences of Food Allergy and Intolerance on the Rise among Americans
  • Pain Killer Abuse Leads to High Incident of Drug Allergy Reactions
  • US Witnesses Increasing Popularity of At-Home Allergy Diagnostic Kits
  • US Offers Favorable Reimbursements for Allergy Testing
  • Market Analytics
CANADA

JAPAN

CHINA

EUROPE
  • Market Facts & Figures
  • Food Allergy: Regulatory Overview
  • EU FIC Regulation
  • Soy Allergy Regulations
  • Egg Allergy Regulations
  • Market Analytics
FRANCE

GERMANY

ITALY

UNITED KINGDOM

SPAIN

RUSSIA

REST OF EUROPE

ASIA-PACIFIC
  • Market Facts & Figures
  • Allergy: An Overview
  • Market Analytics
AUSTRALIA

INDIA
  • Market Facts & Figures
  • Food Allergies and Intolerances on the Rise among Indians
  • Market Analytics
SOUTH KOREA

REST OF ASIA-PACIFIC

LATIN AMERICA

ARGENTINA

BRAZIL

MEXICO

REST OF LATIN AMERICA

MIDDLE EAST

IRAN

ISRAEL

SAUDI ARABIA

UNITED ARAB EMIRATES

REST OF MIDDLE EAST

AFRICA

IV. COMPETITION
  • Total Companies Profiled: 61
Note: Product cover images may vary from those shown
Adroll
adroll